Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARTUP
PACTR202611599546686Phase 4Not yet recruiting
- Sponsor
- Moi University College of Health Sciences
- Start
- May 2027
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of primaquine, sulfadoxine, pyrimethamine and amodiaquine in malaria (2 arms), sponsored by Moi University College of Health Sciences. Primary endpoint: Clinical malaria in household members. Planned start May 2027; status: not yet recruiting.
02
Drugs
primaquinesulfadoxinepyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202611599546686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202611599546686.